Navigation Links
Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients

ally to assess the safety of ISIS 301012 in HoFH and in combination with high-dose concurrent lipid-lowering therapies, the protocol initially called for five weeks of dosing. Based on a strong safety profile at five weeks with doses through 200 mg/week, the study was amended to include a cohort of patients dosed at 300 mg/week for three months, and it is that cohort for which Isis is updating the interim data presented at the ACC. Because HoFH is an extremely rare condition affecting one person per million, clinical trials in this disease are generally quite small.

The study included three HoFH patients with very high incoming LDL-cholesterol levels despite being treated with maximally-tolerated lipid-lowering therapies. Throughout the study, all patients remained on their other lipid-lowering drugs at constant doses. With this update, all patients completed 12 weeks of study treatment and reached the primary endpoint for analysis at Day 99, 14 days after receiving their last dose of ISIS 301012. The patients continue in follow-up. The data are summarized in tabular form below.



    Table 1: ISIS 301012 in HoFH, Summary of Results

    Lipid values are presented in mg/dL and % change from baseline.


                  Patient 1         Patient 2          Patient 3


                                      80 mg

                                   atorvastatin +

    Concurrent                   10 mg ezetimibe +

    Lipid-                            3.75 g              40 mg

    lowering        80 mg          colesevelam +      rosuvastatin +

    Therapies    atorvastatin       1 g niacin        10 mg ezetimibe


    Age

     (years)        23                  48                  32


    Lipids: Base-   Day    %     Base- Day    %     Base-  Day    %

            line    99   change  line  99   change  line   99   change

    ApoB     369    171   -54%   180   103   -43%   283    156   -45%

    LDL-C    651    318   -51%   197    99   -50%   4
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:3/5/2015)... VIENNA , March 5, 2015 ... announce the new generation of OASIS *    ... with enhanced processing power will set a benchmark for ... overcome obstacles and prevent delays whilst optimizing workflow management ... quality, patient comfort and safety for imaging in Neurology, ...
(Date:3/5/2015)... MENLO PARK, Calif. , March 5, 2015 /PRNewswire/ ... company in the emerging field of regenerative medicine, announced ... one of the nation,s top rehabilitation hospitals for spinal ... the Phase 1/2a clinical trial of AST-OPC1 (oligodendrocyte progenitor ... complete cervical spinal cord injury (SCI). ...
(Date:3/5/2015)... Denmark , March 5, 2015 ... that applies its innovative TransCon technology to address ... present two posters at the ENDO 2015 conference ... The posters will be presented on Thursday, March ... is being held from 1:00pm-3:00pm PST, and are ...
Breaking Medicine Technology:Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4Ascendis Pharma to Present at ENDO 2015 2
... , , ATLANTA , Feb. ... Board: GOVX) (the "Company"), an Atlanta -based, biopharmaceutical company ... Virus) and other infectious agents, today provided an update on ... grow at an alarming rate, 60,000 new infections annually, and ...
... , ABBOTT PARK, Ill., Feb. 8 A new ... common form of ovarian cancer may soon be available in ... a simple blood test to help in monitoring for the recurrence ... would be the first automated HE4 test available in the ...
Cached Medicine Technology:GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 2GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 3GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 4GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 5GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 6Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval 2Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval 3
(Date:3/6/2015)... FL (PRWEB) March 06, 2015 The producers ... March 2015 air dates for Spokane, Washington and vicinity. This ... places to shop and dine, and many outdoor activities. It ... supporting the local economy. Six major hospitals call the city ... the Canadian border. The medically-focused cable TV program will be ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Fluid Running® ... Marathon qualifier, developed the Fluid Running® method ... before the Chicago marathon. She hit upon the trifecta ... group run, and a maximum-resistance, deep water running technique. ... unique no-impact, deep water running workout that made the ...
(Date:3/6/2015)... Diego, CA (PRWEB) March 06, 2015 ... findings continue to be discussed, Ford & Associates Nationwide ... of a January 2015 filed lawsuit: Verduzco v. Daiichi ... Northern District of California. , “In light of ... who have used Benicar to evaluate and explore the ...
(Date:3/5/2015)... 2015 From Oct. 5-10, Mumbai, India will ... Conference . These dates include the following activities:, ... , October 6: Conference Day 1, ending with ... Conference Day 2, ending with Local Entertainment and Dinner , ... and other Materials Meetings , October 9-10: Textiles ...
(Date:3/5/2015)... global digital PCR (dPCR) and qPCR market is expected to reach ... 2019. , The global digital PCR (dPCR) and qPCR market is ... 2019. Although the mature markets such as the U.S., Germany, France ... qPCR market the Asia-Pacific region is expected to grow at the ... the digital PCR (dPCR) and qPCR market is driven by factors ...
Breaking Medicine News(10 mins):Health News:The Health Briefs TV Show to Air in Spokane, Washington 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 4Health News:Textile Exchange Announces the 2015 Textile Sustainability Conference Dates 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4
... everyone can exercise in some way. For some people, ... are many options in exercise machines to help burn ... your age, activity preferences, budget and health, some aerobic ... The October issue of Mayo Clinic Health Letter covers ...
... depression have been found to be immediately effective ... that may be as effective as active psychotherapies ... National University. ,The yet-to-be-published findings by Professors ... Griffiths at the Centre for Mental Health Research ...
... Food Safety and Inspection Service (FSIS) have brought to ... of pork products that were manufactured on September 13,18,19,2006 ... the state of Ohio , and Columbia have been ... established through microbiological testing. ,Following this discovery more ...
... the toll to 25 Saturday while 95 new patients were ... cases in Delhi has now risen to 1,373. ... Farahan of Delhi. She was brought to the All India ... the early hours of Saturday, said medical officials. ...
... eight-month ban on the import of poultry, eggs and related ... avian flu-free.// ,Bhutan had imposed an indefinite ban on ... the outbreak of the H5N1 virus in poultry in India's ... the avian virus, which had led to the culling of ...
... farm has led to the culling of over 15,000 birds. ... a 3km protection zone and a 10km surveillance zone have been ... ,According to the Scottish Executive the disease did not ... can spread rapidly in poultry of all types, and all birds ...
Cached Medicine News:Health News:Home Is Where the Gym Is 2Health News:Depression Benefitted by Internet-based Interventions 2Health News:Dengue Claims Yet Another Victim in Delhi 2Health News:Bhutan Lifts Ban on Poultry from India 2
... Prefab Orthosis For quick, efficient immobilization ... shell immobilizes and protects the fracture ... adds comfort, support, and conformity to ... the shell may be gently heated ...
Finger /Thumb Splint has a stay that may be shaped to hold finger or thumb in exact degree of flexion. It also has a contact closure....
Combination Oppenheimer with Knuckle Bender - to dorsiflex wrist and flex MCP joints; includes two attachments to extend/flex distal finger joints....
Bunell Mini-Modified Safety Finger Pin reduces PIP flexion contractures....
Medicine Products: